Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, HSTM, MDRX, RRAC, AXAC, ENPC, DHHC, EVE, and PRPB

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Rigel Resource Acquisition (RRAC), AXIOS Sustainable Growth Acquisition (AXAC), Executive Network Partnering (ENPC), DiamondHead (DHHC), EVe Mobility Acquisition (EVE), and CC Neuberger Principal Holdings II (PRPB).

Athena Technology Acquisition vs. Its Competitors

Athena Technology Acquisition (NYSE:ATEK) and Cortexyme (NASDAQ:CRTX) are both small-cap health care technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

17.3% of Athena Technology Acquisition shares are owned by institutional investors. Comparatively, 63.2% of Cortexyme shares are owned by institutional investors. 88.4% of Athena Technology Acquisition shares are owned by company insiders. Comparatively, 27.9% of Cortexyme shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Cortexyme had 1 more articles in the media than Athena Technology Acquisition. MarketBeat recorded 1 mentions for Cortexyme and 0 mentions for Athena Technology Acquisition. Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Athena Technology Acquisition Neutral
Cortexyme Neutral

Athena Technology Acquisition has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Cortexyme has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500.

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
Athena Technology AcquisitionN/A N/A N/A
Cortexyme N/A -70.96%-63.53%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Athena Technology AcquisitionN/AN/AN/AN/AN/A
CortexymeN/AN/A-$89.94M-$2.97-0.57

Summary

Athena Technology Acquisition beats Cortexyme on 4 of the 7 factors compared between the two stocks.

Get Athena Technology Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE Exchange
Market Cap$101.50M$212.91M$2.00B$20.69B
Dividend YieldN/A3.27%13.62%3.67%
P/E RatioN/A1.9212.2829.07
Price / SalesN/A560.252,512,256.8066.55
Price / CashN/A115.7757.4622.84
Price / BookN/A8.973.094.43
Net IncomeN/A-$11.33M-$461.08M$994.22M

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$10.00
flat
N/AN/A$101.50MN/A0.002,021
CRTX
Cortexyme
N/A$1.86
+5.1%
N/A+127.2%$56.08MN/A-0.6355News Coverage
OMCL
Omnicell
3.484 of 5 stars
$28.13
-0.2%
$45.33
+61.2%
-23.4%$1.32B$1.11B61.153,670Trending News
Earnings Report
HSTM
HealthStream
4.449 of 5 stars
$26.95
-0.7%
$31.50
+16.9%
-14.2%$828.46M$291.65M42.781,093Positive News
Upcoming Earnings
MDRX
Veradigm
2.8817 of 5 stars
$4.83
+3.9%
$13.00
+169.2%
-50.3%$522.92M$1.53B0.008,000
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
AXAC
AXIOS Sustainable Growth Acquisition
N/A$10.43
flat
N/AN/A$228.66MN/A0.00N/AHigh Trading Volume
ENPC
Executive Network Partnering
N/A$5.29
+0.8%
N/A-20.2%$222.25MN/A0.001
DHHC
DiamondHead
N/A$4.15
+5.1%
N/A-30.4%$178.99MN/A0.002
EVE
EVe Mobility Acquisition
N/A$11.27
flat
$5.00
-55.6%
N/A$175.77MN/A0.004
PRPB
CC Neuberger Principal Holdings II
N/A$2.01
+2.6%
N/A-51.4%$166.43MN/A0.004High Trading Volume

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners